Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GREEN, J.
Right arrow Articles by ABASSI, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GREEN, J.
Right arrow Articles by ABASSI, Z.
J Am Soc Nephrol 11:1188-1198, 2000
© 2000 American Society of Nephrology


REGULAR ARTICLES

Differential Effects of Sera from Normotensive and Hypertensive Pregnant Women on Ca2+ Metabolism in Normal Vasular Smooth Muscle Cells

JACOB GREEN*, SUHEIR ASSADY*, FARID NAKHOUL*, TOVA BICK*, PETER JAKOBI{ddagger} and ZAID ABASSI{dagger}

* Department of Nephrology, Rambam Medical Center, B. Rappaport Faculty of Medicine, Technion, Haifa, Israel
{dagger} Department of Physiology and Biophysics, Rambam Medical Center, B. Rappaport Faculty of Medicine, Technion, Haifa, Israel
{ddagger} Obstetrics and Gynecology, Rambam Medical Center, B. Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Correspondence to Dr. Jacob Green, Department of Nephrology, Rambam Medical Center, Bat-Galim Haifa 31096, Israel. Phone : +972 4 8543251 ; Fax : + 972 4 8542946 ; E-mail greeny{at}rambam.health.gov.il

Abstract. The clinical features of preeclampsia have been traditionally ascribed to a generalized vascular endothelial cell dysfunction. The present study investigates the effect of sera from preeclamptic women and normal pregnancy on the metabolism of intracellular Ca2+ concentration ([Ca2+]i) in normal cultured vascular smooth muscle cells (VSMC). Sera were obtained from normotensive pregnant women (NTP) (n = 17), preeclamptic women (PE) (n = 15), pregnant women with chronic (essential) hypertension (pregnant EHT) (n = 8), non-pregnant women with essential hypertension (non-pregnant EHT) (n = 12), and age-matched non-pregnant normotensive women (NNP) (n = 18). Serum (10%) was applied to both primary cultures of rat aortic smooth muscle cells and to the A-10 vascular muscle cell line. Levels of [Ca2+]i were determined fluorometrically. After a 4-h incubation with serum, basal [Ca2+]i was not significantly altered. However, compared with normal pregnant sera, PE sera markedly reduced hormonally induced Ca2+ transients. Thus, following acute stimulation of rat VSMC (primary cultures) with 10-8M angiotensin II, peak [Ca2+]i responses (% increment over baseline) were 443 ± 22, 184 ± 18, 259 ± 12, 274 ± 23, and 255 ± 15% in NTP, PE, pregnant EHT, non-pregnant EHT, and NNP, respectively (P <0.01 PE versus NTP, P <0.05 PE versus NNP and pregnant and non-pregnant EHT). These effects of sera on [Ca2+]i were qualitatively reproduced in platelets obtained from healthy volunteers. Also, depolarization-activated Ca2+ influx in VSMC was affected by the different sera groups in a manner similar to that seen with hormonally induced [Ca2+]i responses. The altered [Ca2+]i changes by PE sera disappeared 5 wk after delivery. The effect of the different sera groups on hormonally triggered Ca2+ transients in normal VSMC, as well as the normalization of [Ca2+]i responses after delivery, suggest the presence of a circulating serum factor in PE. Inasmuch as [Ca2+]i is the major determinant of VSMC tone, it is possible that consequent to the attenuation of [Ca2+]i responses, this putative circulating factor counterbalances the intense vasoconstriction in PE.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP